Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection

PLoS Pathogens
Ursula NeuThilo Stehle


The recently discovered human Merkel cell polyomavirus (MCPyV or MCV) causes the aggressive Merkel cell carcinoma (MCC) in the skin of immunocompromised individuals. Conflicting reports suggest that cellular glycans containing sialic acid (Neu5Ac) may play a role in MCPyV infectious entry. To address this question, we solved X-ray structures of the MCPyV major capsid protein VP1 both alone and in complex with several sialylated oligosaccharides. A shallow binding site on the apical surface of the VP1 capsomer recognizes the disaccharide Neu5Ac-α2,3-Gal through a complex network of interactions. MCPyV engages Neu5Ac in an orientation and with contacts that differ markedly from those observed in other polyomavirus complexes with sialylated receptors. Mutations in the Neu5Ac binding site abolish MCPyV infection, highlighting the relevance of the Neu5Ac interaction for MCPyV entry. Our study thus provides a powerful platform for the development of MCPyV-specific vaccines and antivirals. Interestingly, engagement of sialic acid does not interfere with initial attachment of MCPyV to cells, consistent with a previous proposal that attachment is mediated by a class of non-sialylated carbohydrates called glycosaminoglycans. Our results ...Continue Reading


Jul 2, 2014·Current Opinion in Virology·Samantha D O'HaraRobert L Garcea
Nov 3, 2014·Annual Review of Virology·Luisa J Ströh, Thilo Stehle
Mar 12, 2013·Nature Reviews. Microbiology·James A DeCaprio, Robert L Garcea
Sep 4, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Erik A TeunissenEnrico Mastrobattista
Dec 12, 2012·Virology·Megan E Spurgeon, Paul F Lambert
Oct 17, 2015·PLoS Pathogens·John YouThomas L Benjamin
Dec 14, 2012·PLoS Pathogens·Kerstin ReissThilo Stehle
Aug 31, 2013·PLoS Pathogens·Rachel M Schowalter, Christopher B Buck
Apr 3, 2013·Annales de dermatologie et de vénéréologie·L Misery
Sep 2, 2016·The Journal of General Virology·Friederike NeumannNicole Fischer
Feb 9, 2017·Canadian Journal of Microbiology·Soumen Bhattacharjee, Sutanuka Chattaraj
Jul 21, 2016·Angewandte Chemie·Paul R WratilWerner Reutter
Jan 11, 2019·Journal of Virology·Miriam BeckerMario Schelhaas
Sep 30, 2014·Nature Reviews. Microbiology·Jennifer E Stencel-BaerenwaldTerence S Dermody
Sep 13, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·James A DeCaprio
Jul 1, 2020·Annual Review of Virology·Wei Liu, Jianxin You
Sep 14, 2016·Antiviral Chemistry & Chemotherapy·Sutthiwan ThammawatDavid L Gordon


Nov 28, 1991·Nature·R C LiddingtonS C Harrison
Jan 1, 1987·Methods in Enzymology·G Schwarzmann, K Sandhoff
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·M LiRobert L Garcea
Sep 1, 1995·Journal of Biomolecular NMR·D S WishartB D Sykes
Feb 21, 2002·Lancet·Eric A EngelsRobert W Miller
Aug 28, 2003·The EMBO Journal·Billy TsaiTom A Rapoport
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Oct 14, 2004·Journal of Virology·Sylvia EashW J Atwood
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jan 18, 2006·Journal of Virology·Jonathan A LowMichael J Imperiale
Mar 23, 2006·Acta Crystallographica. Section D, Biological Crystallography·Jay Painter, Ethan A Merritt
Feb 9, 2007·Journal of Virology·Tobias AllanderBjörn Andersson
Aug 19, 2007·The Journal of Investigative Dermatology·Bianca Lemos, Paul Nghiem
Jan 19, 2008·Science·Huichen FengPatrick S Moore
Mar 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ursula NeuThilo Stehle
Sep 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Masahiro ShudaYuan Chang
Nov 11, 2008·Virology·Mengxi JiangMichael J Imperiale
Nov 28, 2008·Journal of Virology·Mengxi JiangMichael J Imperiale
Jan 23, 2009·Virology·Martin Sapp, Patricia M Day
Jul 17, 2009·Journal of Virology·Kimberly D EricksonBilly Tsai
Sep 15, 2009·PLoS Pathogens·Diana V PastranaChristopher B Buck
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 29, 2010·Journal of the National Cancer Institute·Jeanette KaaeMads Melbye
Jun 12, 2010·The Journal of Biological Chemistry·Steven J Gamblin, John J Skehel
Jun 15, 2010·Cell Host & Microbe·Rachel M SchowalterChristopher B Buck
Jul 30, 2010·Journal of Virology·Mengding Qian, Billy Tsai

Related Concepts

GBA wt Allele
Biochemical Pathway
Carbohydrate nutrients
Crystal - Body Material
Antivirals, topical
Enzymes, antithrombotic

Related Feeds


Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.


Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.